Replies to post #107999 on Biotech Values

[zipjet]

Those are good numbers, with market share now up to 47%.

Assuming that share across the entire market, it suggests an annual run rate of $1.125B in sales for Sandoz.

ij

[DewDiligence]

Weekly Branded and Generic Lovenox Scripts

The script share of generic Lovenox has been steadily
climbing since the product launch and is now at 46.9%.

         -No. of Scripts-  Market 
 Week    Branded  Generic  Share of 
 Ending  Lovenox  Lovenox  Generic 
 1022     30,362   26,809  46.9% 
 1015     30,066   26,278  46.6% 
 1008     31,179   25,803  45.3% 
 1001     30,631   25,887  45.8% 
 0924     31,289   25,271  44.7% 
 0917     31,104   24,377  43.9% 
 0910     30,021   21,437  41.7% 
 0903     32,863   22,132  40.2% 
 0827     33,208   20,890  38.6% 
 0820     36,016   18,719  34.2% 
 0813     38,500   16,028  29.4% 
 0806     42,721   11,865  21.7% 
 0730     52,702    1,702   3.1% 
 0723     54,237      *      * 
 0716     54,721      *      * 
 0709     51,269      *      *

*Generic Lovenox was launched on 7/23/10.

[floblu14]

Anyone have the latest script #s for Lov./m-en? Should be close to

50%. T.I.A.

[Rocky3]

Numbers for scripts, including original info:

Week Lov. m-en

7/9 51,269

7/16 54,721

7/23 54,237

7/30 52,702 1,702

8/6 42,721 11,865

8/13 38,500 16,028

8/20 36,016 18,719

8/27 33,208 20,890

9/3 32,863 22,132

9/10 30,021 21,437

9/17 31,104 24,377

9/24 31,289 25,271

10/01 30,631 25,887

10/08 31,179 25,803

10/15 30,066 26,278

10/22 30,362 26,809

10/29 29,753 27,284

11/05 29,456 27,369

11/12 28,568 28,337

11/19 28,101 28,998

11/26 26,202 26,618